Unknown

Dataset Information

Association of Metabolic Dysfunction-Associated Fatty Liver Disease With Risk of HF and AF.


ABSTRACT:

Background

Metabolic dysfunction-associated fatty liver disease (MAFLD) is a novel concept of hepatic disease. Although the prevalences of heart failure (HF) and atrial fibrillation (AF) are increasing worldwide, limited data have assessed the extent to which MAFLD is associated with incident HF and AF.

Objectives

The authors sought to examine the association of MAFLD with incident HF and AF.

Methods

Analyses were conducted using a nationwide epidemiologic database including 3,279,918 individuals (median age 45 years; 57.6% men). Metabolic dysfunction was defined as 1 or more of the following: overweight (body mass index ≥23 kg/m2), metabolic syndrome, or diabetes mellitus. FLD was defined as fatty liver index of >30. MAFLD was defined as the coexistence of

SUBMITTER: Ohno R 

PROVIDER: S-EPMC10751648 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature